Sorrento Therapeutics, Inc. Appoints Former Roche Executive Tammy Reilly to the Board of Directors
SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc (Nasdaq: SRNE, “Sorrento”), a commercial…
News
Capricor Therapeutics to Present at the H.C. Wainwright Global Investment Conference
SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company…
FDA grants Orphan Drug Designation for tasquinimod in myelofibrosis
Lund May 18, 2022 – Active Biotech AB (Nasdaq Stockholm: ACTI) today announced that the…
Ceapro Inc. Reports Record Financial Results for First Quarter 2022 and Provides Corporate Update
– Best quarterly financial results in history of the Company – Q1 2022 sales of…
INmune Bio, Inc. to Present at the H.C. Wainwright Global Hybrid Investment Conference on May 24th
Boca Raton, FL, May 18, 2022 (GLOBE NEWSWIRE) — INmune Bio (NASDAQ: INMB), a clinical…
Novateur Ventures Participates in Founding and Financing of Epitopea, a New Cancer Therapeutics Company
The Newly Founded Company, Epitopea, Has Secured $14 Million in Seed Financing to Advance the…
AVEO Oncology Announces Participation at the H.C. Wainwright Global Investment Conference
BOSTON, May 18, 2022 (GLOBE NEWSWIRE) — AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused…
Veru Announces Appointment of Joel Batten to Lead U.S. Infectious Disease Franchise to Focus on Hospitalized COVID-19 Patients
MIAMI, May 18, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused…
Kane Biotech Obtains ISO 13485 Certification
The quality management system of Kane is certified for design and development of medical devices WINNIPEG,…
Fortress Biotech to Participate in Two Upcoming May 2022 Investor Conferences
MIAMI, May 18, 2022 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative…
Senti Bio Highlights Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells in Three Presentations at ASGCT Annual Meeting
– SENTI-202 oral presentation details systematic optimization of Logic Gating Gene Circuit technology in allogeneic…
Celularity Inc. Announces $30 Million Private Placement Priced At-The-Market Under Nasdaq Rules
FLORHAM PARK, N.J., May 18, 2022 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a…
Outlook Therapeutics to Present at the H.C. Wainwright Global Investment Conference
ISELIN, N.J., May 18, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a pre-commercial…
Caladrius Biosciences to Present at the H.C. Wainwright Global Investment Conference
BASKING RIDGE, N.J., May 18, 2022 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”…
Avadel Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
DUBLIN, Ireland, May 18, 2022 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical…
Applied Molecular Transport Provides Strategy Update
Company streamlines to prioritize resources on key proprietary clinical programs, including plans to advance AMT-101…
Aeterna Zentaris to Present at the H.C. Wainwright Global Investment Conference
TORONTO, ONTARIO, May 18, 2022 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS)…
Baudax Bio to Present at the H.C. Wainwright Annual Global Life Sciences Conference
MALVERN, Pa., May 18, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company…
Oncotelic Announces Pipeline Presentation and IPO Update of Sapu Therapeutics at the 2022 BIO International Convention
AGOURA HILLS, Calif., May 18, 2022 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic” or the…
Cocrystal Pharma to Present at the H.C. Wainwright Global Investment Conference
BOTHELL, Wash., May 18, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that…